Blood

An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils

Conditions:   Asthma;   Elevated Blood EosinophilsInterventions:   Drug: Reslizumab;   Drug: PlaceboSponsor:   Teva Branded Pharmaceutical Products, R&D Inc.Not yet recruiting – verified July 2015 View full post on ClinicalTrials.gov: asthma | received in the last 14 days